Search research articles

お問い合わせ

JoVEについて

概要リーダーシップブログ JoVEヘルプセンター

著者向け

出版プロセス編集委員会範囲と方針査読よくある質問投稿

図書館員向け

推薦の声購読アクセスリソース図書館諮問委員会よくある質問

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments アーカイブ

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教員リソースセンター教員サイト

プライバシーポリシー

関連する概念動画

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え

Same author

Methylation plus alpha-fetoprotein blood test for early detection of HCC in at-risk populations.

Hepatology communications·2026

Same author

A Major Step toward a Cure for Hepatitis B Infection.

The New England journal of medicine·2026

Same author

Hepatitis B: A Review.

JAMA·2026

Same author

Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosis.

Hepatology communications·2026

Same author

A Self-Reported Electronic Body Map Identifies Distinct Clinical Pain Phenotypes in Chronic Pancreatitis.

Clinical and translational gastroenterology·2026

Same author

Animal Naming Test Predicts Future Overt Hepatic Encephalopathy.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026

Same journal

Deescalation, Discontinuation, and Deimplementation Trials: Evaluating Whether and How to Do Less.

JAMA·2026

Same journal

Surgical and Endoscopic Therapies for GERD.

JAMA·2026

Same journal

The Psychedelic Therapies Executive Order: On Approval and Clinical Readiness.

JAMA·2026

Same journal

"Suturing": Love, Death, and Perfection's Limits.

JAMA·2026

Same journal

What Is Low Back Pain?

JAMA·2026

Same journal

From Silicon Valley to the Vatican-The Expanding Debate on AI Ethics.

JAMA·2026

関連記事をすべて見る

Search research articles

関連する実験動画

Updated: Jul 11, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

肝炎 D: レビュー

Francesco Negro¹, Anna S Lok²

¹Division of Gastroenterology and Hepatology, Geneva University Hospitals, Geneva, Switzerland.

|November 9, 2023

まとめ

この要約は機械生成です。

肝炎Dウイルス (HDV) 感染は,しばしば肝炎Bウイルス (HBV) で発生し,肝疾患の進行を加速します. ブレヴァルチドのような新しい治療法は臨床試験でこの重要な世界的な健康問題に対処する可能性を示しています

科学分野:

肝病学とウイルス学

さらに関連する動画

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

関連する実験動画

Last Updated: Jul 11, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

感染症

胃腸内科

背景:

肝炎Dウイルス (HDV) と肝炎Bウイルス (HBV) の共感染は,世界中で何百万人に感染し,肝硬変や肝細胞癌を含むより重度の肝疾患を引き起こす.
慢性 HBV 感染者における HDV 超感染は,肝硬変と死亡率の高度の急速な進行を伴うが,疾患の進行は変動する可能性がある.

結論:

HDVは,その攻撃的な性質と重度の肝臓合併症と関連しているため,世界的な健康上の負担を大きくします.
アルファインターフェロンはある程度の効果があるが,副作用は一般的であり,HBVを標的とした治療はHDVに対して無効である.
ブレヴァルチドのような新興治療は,慢性HDV感染の管理における重要な進歩であり,治療戦略を最適化するための研究が進行中です.